Maintaining Control
Improving QC choice = Improved diagnostics
Read MorePosted by Judy O'Rourke | Sep 6, 2013 | Miscellaneous |
Improving QC choice = Improved diagnostics
Read MorePosted by Judy O'Rourke | Sep 5, 2013 | Cancer, Molecular Diagnostics |
The test is being released in a phased approach beginning with an early-access, clinical-experience program to a limited number of medical and scientific thought leaders, followed by an expanded-access program later in the year.
Read MorePosted by Judy O'Rourke | Sep 4, 2013 | Molecular Diagnostics |
Molecular biology is continuing to revolutionize disease diagnosis. Modern molecular tests based on the detection of nucleic acids (ie, DNA and RNA) offer considerable advantages over traditional methods of pathogen detection.
Read MorePosted by Judy O'Rourke | Sep 4, 2013 | Molecular Diagnostics, Research |
The initiative aims to help us better understand how to use genomic sequencing to improve health and prevent disease in infants and children.
Read MorePosted by Judy O'Rourke | Sep 3, 2013 | Uncategorized |
Sandra S. Park, JD, lead counsel in the lawsuit challenging gene patents held by Myriad Genetics, discusses the case, and Federico Monzon, MD, director of Molecular Pathology, Cancer Genetics Laboratory, Baylor University, discusses its impacts.
Read More